financetom
Business
financetom
/
Business
/
Serabi Q3 Gold Production Rises YoY, Releases Updated Pre-Economic Assessment for Coringa Project
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Serabi Q3 Gold Production Rises YoY, Releases Updated Pre-Economic Assessment for Coringa Project
Oct 21, 2024 2:02 PM

06:50 AM EDT, 10/21/2024 (MT Newswires) -- Serabi Gold ( SRBIF ) , the Brazilian-focused gold mining and development company, on Monday reported third-quarter production of 9,489 ounces of gold, up from 8,738 ounces of gold in the same quarter last year.

The company mined 58,862 tonnes of ore at 5.48 grams per tonne (g/t) gold grade, compared with 44,744 tonnes of ore at 6.64 g/t gold grade.

Ore milled amounted to 54,579 tonnes at 5.59 g/t gold grade, compared with 43,092 tonnes at 6.72 gold grade.

Serabi reiterated full-year 2024 consolidated gold production guidance of 38,000 to 40,000 ounces.

The company also released results of the updated pre-economic assessment (PEA) for its Coringa gold operation in Brazil.

Highlights of the PEA include annual production of 28,000 ounces in 2025, ramping up to 36,000 ounces per year between 2026 and 2031 with an 11-year mine life until 2034 at an average life of mine all-in sustaining cost of US$1,241 per ounce.

After-tax net present value, discounted at 10%, was US$145 million with average life of mine annual free cash flow of US$19 million using a long-term gold price of US$2,100 per ounce.

"We are tracking well towards guidance, and with the classification plant progressing according to plan at Coringa, we remain very optimistic for the remainder of the year," said Serabi CEO Mike Hodgson.

Serabi Gold's ( SRBIF ) share price at last look gained 4.7% to 90 pence in London trading on Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Revolution Medicines Insider Sold Shares Worth $427,965, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $427,965, According to a Recent SEC Filing
Mar 20, 2026
04:28 AM EDT, 03/20/2026 (MT Newswires) -- Stephen Michael Kelsey, President of Research and Development, on March 17, 2026, sold 4,302 shares in Revolution Medicines ( RVMD ) for $427,965. Following the Form 4 filing with the SEC, Kelsey has control over a total of 295,398 common shares of the company, with 295,398 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071726000131/xslF345X05/form4.xml ...
Astera Labs Insider Sold Shares Worth $20,723,773, According to a Recent SEC Filing
Astera Labs Insider Sold Shares Worth $20,723,773, According to a Recent SEC Filing
Mar 20, 2026
04:28 AM EDT, 03/20/2026 (MT Newswires) -- Jitendra Mohan, Director, Chief Executive Officer, on March 17, 2026, sold 157,500 shares in Astera Labs ( ALAB ) for $20,723,773. Following the Form 4 filing with the SEC, Mohan has control over a total of 8,984,472 common shares of the company, with 1,452,739 shares held directly and 7,531,733 controlled indirectly. SEC Filing:...
Revolution Medicines Insider Sold Shares Worth $1,280,412, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $1,280,412, According to a Recent SEC Filing
Mar 20, 2026
04:29 AM EDT, 03/20/2026 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on March 17, 2026, sold 12,871 shares in Revolution Medicines ( RVMD ) for $1,280,412. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 999,606 common shares of the company, with 276,698 shares held directly and 722,908 controlled...
Revolution Medicines Insider Sold Shares Worth $455,919, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $455,919, According to a Recent SEC Filing
Mar 20, 2026
04:30 AM EDT, 03/20/2026 (MT Newswires) -- Margaret A Horn, Chief Operating Officer, on March 17, 2026, sold 4,583 shares in Revolution Medicines ( RVMD ) for $455,919. Following the Form 4 filing with the SEC, Horn has control over a total of 157,570 common shares of the company, with 157,570 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071726000129/xslF345X05/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved